Recombinant Human PSMC1 Protein，His

PSMC1, or proteasome 26S subunit ATPase 1, is a vital component of the 26S proteasome, a complex responsible for degrading ubiquitinated proteins in eukaryotic cells. This process is crucial for various cellular functions, including the regulation of the cell cycle, modulation of signaling pathways, and the maintenance of protein homeostasis. Recent studies have highlighted the significance of PSMC1 in cancer biology, where its dysregulation is often linked to tumor progression and resistance to therapy. The overexpression of PSMC1 has been observed in several cancer types, suggesting it may function as an oncogene. Furthermore, PSMC1's role in the unfolding and translocation of substrate proteins into the proteasome has garnered attention for potential therapeutic interventions. The recombinant expression and study of PSMC1 provide insights into its structure-function relationship, enzymatic activity, and interaction with other proteasome subunits. As researchers explore PSMC1 as a biomarker for malignancies and a potential target for drug development, understanding its mechanisms of action and regulatory pathways has become increasingly important in the context of targeted therapies and personalized medicine. The ongoing investigation into PSMC1 and its reconstituted proteins aims to unveil new avenues for cancer treatment and provide a foundational understanding of proteasomal regulation in normal and pathological states.